FGF-2 and FGF-16 Protect Isolated Perfused Mouse Hearts from Acute Doxorubicin-Induced Contractile Dysfunction
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGF-2 and FGF-16 Protect Isolated Perfused Mouse Hearts from Acute Doxorubicin-Induced Contractile Dysfunction
Authors
Keywords
Doxorubicin, Cardioprotection, Mouse Langendorff preparation, Developed pressure, FGF-2, FGF-16
Journal
Cardiovascular Toxicology
Volume 13, Issue 3, Pages 244-253
Publisher
Springer Nature
Online
2013-02-21
DOI
10.1007/s12012-013-9203-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FGF-2 protects cardiomyocytes from doxorubicin damage via protein kinase C-dependent effects on efflux transporters
- (2013) Jie Wang et al. CARDIOVASCULAR RESEARCH
- Berberine Attenuates Doxorubicin-Induced Cardiotoxicity in Mice
- (2013) X Zhao et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Cytotoxicity of quinone drugs on highly proliferative human leukemia T cells: Reactive oxygen species generation and inactive shortened SOD1 isoform implications
- (2012) Juan Ignacio Aguiló et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density
- (2012) Yabo Wang et al. LASERS IN SURGERY AND MEDICINE
- Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus
- (2011) L. L. SWYSTUN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Early effects of doxorubicin in perfused heart: transcriptional profiling reveals inhibition of cellular stress response genes
- (2010) Malgorzata Tokarska-Schlattner et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Role of NF-kB, p53, and p21 in the Regulation of TNF-α Mediated Apoptosis of Lymphocytes
- (2010) N. V. Ryazantseva et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- FGF-16 is a target for adrenergic stimulation through NF- B activation in postnatal cardiac cells and adult mouse heart
- (2010) A. G. Sofronescu et al. CARDIOVASCULAR RESEARCH
- Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway
- (2010) Hong-Jye Hong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia–reperfusion injury
- (2010) Siyun Liao et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction
- (2010) A. Das et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart
- (2010) David Montaigne et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development
- (2008) Shun Yan Lu et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart
- (2008) Yuhei Hotta et al. DEVELOPMENTAL DYNAMICS
- A Myocyte Enhancer Factor 2 (MEF2) Site Located in a Hypersensitive Region of the FGF16 Gene Locus Is Required for Preferential Promoter Activity in Neonatal Cardiac Myocytes
- (2008) Alina G. Sofronescu et al. DNA AND CELL BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started